UY25069A1 - Procedimiento para preparación de 5-(etil-2-h-tetrazol-5-il)-1-metil-1,2,3,6-tetrahidropiridina - Google Patents
Procedimiento para preparación de 5-(etil-2-h-tetrazol-5-il)-1-metil-1,2,3,6-tetrahidropiridinaInfo
- Publication number
- UY25069A1 UY25069A1 UY25069A UY25069A UY25069A1 UY 25069 A1 UY25069 A1 UY 25069A1 UY 25069 A UY25069 A UY 25069A UY 25069 A UY25069 A UY 25069A UY 25069 A1 UY25069 A1 UY 25069A1
- Authority
- UY
- Uruguay
- Prior art keywords
- maleic acid
- acid addition
- addition salt
- tetrahydropyridine
- ethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente invención tiene por objetivo proporcionar una forma sólida farmacéuticamente aceptable del compuesto 5-(2-etil-2-H-tetrazol-5-il)-1-metil-1,2,3,6-tetrahidropiridina adecuado para la producción a gran escala de entidades farmacéuticas sólidas, por ejemplo tabletas o cápsulas. De acuerdo a la presente invención, se han suministrado sal de adición de ácido maleico de 5-(2-etil-2-H-tetrazol-5-il)-1-metil-1,2,3,6-tetrahidropiridina y las composiciones farmacéuticas que contienen la sal de adición ácida y el uso de las mismas para el tratamiento de trastornos causados por un mal funcionamiento de la acetilcolina(AcCh) o del sistema muscarínico. Por lo tanto se utiliza, por ejemplo, para tratar el mal de Alzheimer, lesiones traumáticas de cerebro o trastornos psicóticos. La sal de adición de ácido maleico, de acuerdo con la invención, puede obtenerese mediante tratamiento de 5-(2-etil-2-H-tetrazol-5-il)-1-metil-1,2,3,6-tetrahidropiridina o un derivado de sal de la misma con ácido maleico en un solvente inerte, seguido de precipitación, separación y opcionalmente recristalización mediante métodos conocidos y si se desea seguido de micronización del producto cristalino mediante molido húmedo, en seco o mediante cualquier otro proceso conveniente o mediante preparación de partículas de un proceso de emulsificación-disolvente. La precipitación de sal de maleato se realiza en un disolvente aprótico inerte, preferentemente tetrahidrofurano (THF). La sal de adición de ácido maleico es la sal de adición de ácido mono-maleico.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK78197 | 1997-07-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY25069A1 true UY25069A1 (es) | 1998-12-21 |
Family
ID=8097489
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY25069A UY25069A1 (es) | 1997-07-01 | 1998-06-29 | Procedimiento para preparación de 5-(etil-2-h-tetrazol-5-il)-1-metil-1,2,3,6-tetrahidropiridina |
| UY25177A UY25177A1 (es) | 1997-07-01 | 1998-09-10 | 5-(2-etil-2-h-tetrazol-5-il)-1-metil-1,2,3,6-tetrahidropiridina |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY25177A UY25177A1 (es) | 1997-07-01 | 1998-09-10 | 5-(2-etil-2-h-tetrazol-5-il)-1-metil-1,2,3,6-tetrahidropiridina |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0994869A1 (es) |
| JP (1) | JP2002507215A (es) |
| KR (1) | KR20010014297A (es) |
| CN (1) | CN1261361A (es) |
| AR (1) | AR013096A1 (es) |
| AU (1) | AU735751B2 (es) |
| BG (1) | BG103933A (es) |
| BR (1) | BR9810331A (es) |
| CA (1) | CA2293324A1 (es) |
| CO (1) | CO4940483A1 (es) |
| EA (1) | EA200000081A1 (es) |
| HU (1) | HUP0002876A2 (es) |
| IL (1) | IL133093A0 (es) |
| IS (1) | IS5278A (es) |
| JO (1) | JO2031B1 (es) |
| MA (1) | MA25138A1 (es) |
| NO (1) | NO996580D0 (es) |
| PE (1) | PE116099A1 (es) |
| PL (1) | PL337184A1 (es) |
| SK (1) | SK187399A3 (es) |
| TN (1) | TNSN98120A1 (es) |
| TR (1) | TR199903283T2 (es) |
| UY (2) | UY25069A1 (es) |
| WO (1) | WO1999001448A1 (es) |
| ZA (1) | ZA985498B (es) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8714789D0 (en) * | 1987-06-24 | 1987-07-29 | Lundbeck & Co As H | Heterocyclic compounds |
| PL326490A1 (en) * | 1995-11-06 | 1998-09-28 | Lundbeck & Co As H | Treatment of traumatic brain injuries |
-
1998
- 1998-06-18 AR ARP980102925A patent/AR013096A1/es not_active Application Discontinuation
- 1998-06-24 ZA ZA985498A patent/ZA985498B/xx unknown
- 1998-06-25 PE PE1998000563A patent/PE116099A1/es not_active Application Discontinuation
- 1998-06-25 JO JO19982031A patent/JO2031B1/en active
- 1998-06-26 CO CO98036576A patent/CO4940483A1/es unknown
- 1998-06-29 UY UY25069A patent/UY25069A1/es not_active Application Discontinuation
- 1998-06-30 TN TNTNSN98120A patent/TNSN98120A1/fr unknown
- 1998-07-01 JP JP50616699A patent/JP2002507215A/ja active Pending
- 1998-07-01 BR BR9810331-8A patent/BR9810331A/pt not_active Application Discontinuation
- 1998-07-01 TR TR1999/03283T patent/TR199903283T2/xx unknown
- 1998-07-01 IL IL13309398A patent/IL133093A0/xx unknown
- 1998-07-01 MA MA25155A patent/MA25138A1/fr unknown
- 1998-07-01 AU AU81020/98A patent/AU735751B2/en not_active Ceased
- 1998-07-01 CN CN98806497A patent/CN1261361A/zh active Pending
- 1998-07-01 PL PL98337184A patent/PL337184A1/xx unknown
- 1998-07-01 WO PCT/DK1998/000294 patent/WO1999001448A1/en not_active Application Discontinuation
- 1998-07-01 EP EP98930655A patent/EP0994869A1/en not_active Withdrawn
- 1998-07-01 KR KR1019997012429A patent/KR20010014297A/ko not_active Application Discontinuation
- 1998-07-01 EA EA200000081A patent/EA200000081A1/ru unknown
- 1998-07-01 CA CA002293324A patent/CA2293324A1/en not_active Abandoned
- 1998-07-01 HU HU0002876A patent/HUP0002876A2/hu unknown
- 1998-07-01 SK SK1873-99A patent/SK187399A3/sk unknown
- 1998-09-10 UY UY25177A patent/UY25177A1/es not_active Application Discontinuation
-
1999
- 1999-11-30 IS IS5278A patent/IS5278A/is unknown
- 1999-11-30 BG BG103933A patent/BG103933A/xx unknown
- 1999-12-30 NO NO996580A patent/NO996580D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999001448A1 (en) | 1999-01-14 |
| PE116099A1 (es) | 1999-11-23 |
| CO4940483A1 (es) | 2000-07-24 |
| EA200000081A1 (ru) | 2000-08-28 |
| SK187399A3 (en) | 2000-06-12 |
| TNSN98120A1 (fr) | 2005-03-15 |
| KR20010014297A (ko) | 2001-02-26 |
| JO2031B1 (en) | 1999-05-15 |
| NO996580L (no) | 1999-12-30 |
| TR199903283T2 (xx) | 2000-06-21 |
| IL133093A0 (en) | 2001-03-19 |
| AU735751B2 (en) | 2001-07-12 |
| UY25177A1 (es) | 2000-12-29 |
| CA2293324A1 (en) | 1999-01-14 |
| PL337184A1 (en) | 2000-08-14 |
| AR013096A1 (es) | 2000-12-13 |
| IS5278A (is) | 1999-11-30 |
| AU8102098A (en) | 1999-01-25 |
| MA25138A1 (fr) | 2001-04-02 |
| NO996580D0 (no) | 1999-12-30 |
| BR9810331A (pt) | 2000-09-05 |
| EP0994869A1 (en) | 2000-04-26 |
| CN1261361A (zh) | 2000-07-26 |
| BG103933A (en) | 2000-07-31 |
| JP2002507215A (ja) | 2002-03-05 |
| HUP0002876A2 (hu) | 2001-06-28 |
| ZA985498B (en) | 1999-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69823994T2 (de) | 8-azabicyclo(3,2,1)oct-2-en- und octanderivate als liganden der nicotinergen ach rezeptoren | |
| DE69819891T2 (de) | Spiro chinuclidin-derivate, ihre herstellung und verwendung | |
| HUT37780A (en) | Process for producing n-/4-piperidyl/-substituted bicyclic condensed 2-imidazolyl-amine derivatives and pharmaceutical compositions containing them as active agents | |
| CN102448958A (zh) | 嘧啶基和1,3,5-三嗪基苯并咪唑磺酰胺和其在癌症治疗中的用途 | |
| DE60309740T2 (de) | 1,4-dizabicyclo(3,2,2)nonane derivative, verfahren zu ihrer herstellung und therapeutical verwendung | |
| HUT61981A (en) | Process for producing unsaturated hydroxyalkylquinoline acids and pharmaceutical compositions comprising same as active ingredient | |
| IT1229203B (it) | Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative. | |
| CN101951766A (zh) | 凋亡抑制蛋白抑制剂 | |
| ATE332686T1 (de) | Verfahren zum herstellen von kristallen, danach erhältliche kristalle und deren verwendung in pharmazeutischen formulierungen | |
| NO903359D0 (no) | Fremgangsmaate for fremstilling av 1,2,3,4-tetrahydro-9-akridinamin-derivater. | |
| FI903835A0 (fi) | Foerfarande foer framstaellning av farmaceutiskt anvaendbara 4-(n-substituerad amino)-2-butynyl-1 -tiourea och deras derivat. | |
| KR20010014316A (ko) | 8-클로로-6,11-디하이드로-11-(4-피페리딜리덴)-5Ｈ-벤조[5,6]사이클로헵타[1,2-ｂ]피리딘의 동질이상체 | |
| UY25069A1 (es) | Procedimiento para preparación de 5-(etil-2-h-tetrazol-5-il)-1-metil-1,2,3,6-tetrahidropiridina | |
| EP1651645B1 (de) | N-biarylamide | |
| ES2009689A6 (es) | Procedimiento para preparar derivados de 3-piperidina-carbaldehido-oxima. | |
| EP1670766B1 (de) | Bicyclische Iminosäurederivate zur Behandlung von (unter anderem) Erkrankungen des Bewegungsapparates | |
| FI891155A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 4,5,6,7-tetrahydroisotiatsolo/4,5-c/pyridiini-johdannaisten ja niiden isomeerien ja happoadditiosuolojen valmistamiseksi | |
| IT8922595A1 (it) | Agente colinergico, in particolare glicil-p-ammino-piridina-anilide- monoacetato, per il trattamento degli stati di demenza senile. | |
| WO2003053956A1 (de) | In 3-position heterocyclisch substituierte piperidin-2,6-dione |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20121204 |